Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update

Go back to Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update
(NASDAQ: TSHA) Delayed: 6.92 +0.39 (5.97%)
Previous Close $6.53    52 Week High
Open $6.47    52 Week Low
Day High $7.06    P/E N/A 
Day Low $6.46    EPS
Volume 1,298,659       

(NASDAQ: TSHA) Delayed: 6.92 +0.39 (5.97%)
Previous Close $6.53    52 Week High
Open $6.47    52 Week Low
Day High $7.06    P/E N/A 
Day Low $6.46    EPS
Volume 1,298,659